Pharmaceutically acceptable salts of 2-{4-[(3S)-piperidin-3yl]phenyl} - 2H-indazole-7-carboxamide

Details for Australian Patent Application No. 2009203598 (hide)

International Classifications

Event Publications

1 July 2010 PCT application entered the National Phase

PCT publication WO2009/087381 Priority application(s): WO2009/087381

21 October 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Ltd; Merck Sharp & Dohme Corporation

4 October 2012 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Ltd; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.